Firvanq Shortage Update: What Patients Need to Know in 2026

If you've been prescribed Firvanq and your pharmacy says it's out of stock, you're probably wondering: Is there an official shortage? Is it getting better or worse? What are my options? This post gives you the most current picture of Firvanq supply in 2026 and exactly what you should do next.

Current Firvanq Supply Status (2026)

As of 2026, Firvanq (vancomycin hydrochloride for oral solution) is not on the FDA's official drug shortage list. However, that doesn't mean it's easy to find everywhere. Patients regularly report difficulty filling Firvanq prescriptions at standard retail pharmacies, while specialty pharmacies and hospital-affiliated pharmacies tend to have it in stock more reliably.

The broader vancomycin supply chain — particularly the IV (intravenous) form — has been under active stress. The ASHP (American Society of Health-System Pharmacists) has had IV vancomycin on its drug shortage list since 2023, with multiple manufacturers including Fresenius Kabi, Pfizer/Hospira, Hikma, and Xellia all reporting supply constraints continuing into 2025 and 2026. While the oral form is less severely affected, the upstream supply pressure contributes to occasional stock gaps for products like Firvanq.

What's Causing Supply Problems for Firvanq?

Several factors create the supply gaps patients experience:

• Specialty product logistics. Firvanq requires cold-chain shipping and refrigerated storage. This limits which distributors and pharmacies can handle it, creating a narrower distribution network.
• Hospital discharge surges. C. diff infections affect more than 500,000 Americans annually. When hospitals discharge patients with Firvanq prescriptions, nearby retail pharmacies can temporarily run out within days.
• Rising antibiotic-resistant infections. Increasing rates of MRSA and antibiotic-resistant C. diff strains have driven up overall demand for vancomycin — all formulations.
• Low routine stocking. Many retail pharmacies don't routinely stock Firvanq and only order it when a prescription comes in, creating a 1-3 day delay that can feel like a shortage.

Is This Shortage Likely to Improve?

The situation for Firvanq specifically is not a catastrophic nationwide shortage — it's more of a distribution and stocking challenge. The underlying vancomycin IV shortage may ease as manufacturers resolve quality control and production issues, which could indirectly improve the entire vancomycin supply chain including oral formulations. However, there is no confirmed timeline for full resolution of IV vancomycin constraints.

For oral Firvanq specifically, availability is expected to remain reasonable at specialty and hospital pharmacies even if retail chains continue to stock it inconsistently.

What Should Patients Do Right Now?

If you're having trouble finding Firvanq, here are your most effective actions:

1. Use medfinder. medfinder.com calls pharmacies near you to find which ones have Firvanq in stock and can fill your prescription today.
2. Call specialty or hospital outpatient pharmacies. These are your best bet for same-day access to Firvanq.
3. Ask your prescriber about alternatives. Generic vancomycin capsules contain the same active ingredient and are widely available at a fraction of the cost. Compounded oral vancomycin solution is another liquid option if you can't swallow capsules.
4. Consider fidaxomicin. If vancomycin isn't available in any form, fidaxomicin (Dificid) is now the preferred first-line agent for C. diff per IDSA 2021 guidelines and may be easier to obtain depending on your area.

38,375+ patients found their medications in stock

38K+

Find Firvanq In Stock Today →

The Bottom Line on the Firvanq Shortage in 2026

Firvanq is not in a formal FDA shortage, but inconsistent stocking means some patients will hit dead ends at retail pharmacies. The solution is to know where to look: specialty pharmacies, hospital-affiliated pharmacies, and medfinder can all help you find it. If you continue to struggle, talk to your prescriber about alternatives to Firvanq — several good options exist that are widely available and clinically equivalent.